Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - ivabradine hydrochloride 8,085 mg - eq. ivabradine 7,5 mg - film-coated tablet - 7,5 mg - ivabradine hydrochloride 8.085 mg - ivabradine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - ivabradine hydrochloride 5,39 mg - eq. ivabradine 5 mg - film-coated tablet - 5 mg - ivabradine hydrochloride 5.39 mg - ivabradine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - ivabradine hydrochloride 8,085 mg - eq. ivabradine 7,5 mg - film-coated tablet - 7,5 mg - ivabradine hydrochloride 8.085 mg - ivabradine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - ivabradine oxalate 5,961 mg - eq. ivabradine 5 mg - film-coated tablet - 5 mg - ivabradine oxalate 5.961 mg - ivabradine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - ivabradine oxalate 8,941 mg - eq. ivabradine 7,5 mg - film-coated tablet - 7,5 mg - ivabradine oxalate 8.941 mg - ivabradine

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 5 milligram - other cardiac preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 7.5 milligram - other cardiac preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - ivabradine hydrochloride, quantity: 8.085 mg (equivalent: ivabradine, qty 7.5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; maltodextrin; colloidal anhydrous silica; glycerol; hypromellose; iron oxide yellow; iron oxide red; macrogol 6000; titanium dioxide - treatment of chronic stable angina,symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers, or in combination with atenolol 50mg once daily when angina is inadequately controlled.,treatment of chronic heart failure,treatment of symptomatic chronic heart failure of nyha classes ii or iii and with documented left ventricular ejection fraction (lvef) less than or equal to 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - ivabradine hydrochloride, quantity: 5.39 mg (equivalent: ivabradine, qty 5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; maltodextrin; colloidal anhydrous silica; glycerol; hypromellose; iron oxide yellow; iron oxide red; macrogol 6000; titanium dioxide - treatment of chronic stable angina,symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers, or in combination with atenolol 50mg once daily when angina is inadequately controlled.,treatment of chronic heart failure,treatment of symptomatic chronic heart failure of nyha classes ii or iii and with documented left ventricular ejection fraction (lvef) less than or equal to 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ivabradine - film coated tablet - 2.5 milligram - other cardiac preparations